Feasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools: The Vanderbilt experience
Author:
Affiliation:
1. Department of Hematology‐Oncology Vanderbilt University Medical Center Nashville Tennessee USA
Publisher
Wiley
Subject
Hematology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18339
Reference12 articles.
1. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
2. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
3. Primary analysis of Zuma‐5: a phase 2 study of Axicabtagene Ciloleucel (Axi‐Cel) in patients with relapsed/refractory (R/R) indolent non‐Hodgkin lymphoma (iNHL);Jacobson C;Blood,2020
4. Overview of approved CAR‐T therapies, ongoing clinical trials, and its impact on clinical practice
5. Chimeric antigen receptor‐T cell therapies: The changing landscape
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy;Transplantation and Cellular Therapy;2024-02
2. Bendamustine lymphodepletion is a well‐tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B‐cell lymphoma;American Journal of Hematology;2023-09-05
3. Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies: A Practical Review;JCO Oncology Practice;2023-09
4. Outpatient CD19‐directed CAR T‐cell therapy is feasible in patients of all ages;British Journal of Haematology;2023-08-29
5. Telemedicine in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T Cell Therapy;Cancers;2023-08-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3